A recent study published on bioRxiv (2026) employed SEC-seq to investigate metabolic strategies in clonal Chinese hamster ovary (CHO) cells that achieve high IgG productivity. The research reveals that high-producing clones prioritize translation-focused metabolism, shifting resources toward protein synthesis rather than growth. This insight could guide cell line engineering to improve monoclonal antibody yields in biopharmaceutical manufacturing.
For full technical details, refer to the original paper: PubMed ID 42039631.